IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
1-Year Return
15.04%
This Quarter Return
+13.95%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$306M
AUM Growth
+$33.1M
(+12%)
Cap. Flow
-$1.33M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
27.94%
Holding
448
New
1
Increased
90
Reduced
50
Closed
272
Top Buys
| 1 |
Linde
LIN
|
$2.84M |
| 2 |
Citizens Financial Group
CFG
|
$2.31M |
| 3 |
Progressive
PGR
|
$1.51M |
| 4 |
Ares Capital
ARCC
|
$903K |
| 5 |
Microsoft
MSFT
|
$479K |
Top Sells
| 1 |
Truist Financial
TFC
|
$1.6M |
| 2 |
Chubb
CB
|
$618K |
| 3 |
Rockwell Automation
ROK
|
$216K |
| 4 |
CVS Health
CVS
|
$214K |
| 5 |
Horace Mann Educators
HMN
|
$207K |
Sector Composition
| 1 | Healthcare | 17.1% |
| 2 | Technology | 16.19% |
| 3 | Consumer Staples | 12.99% |
| 4 | Industrials | 12.4% |
| 5 | Financials | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Accenture
ACN
$158B
| $3.91M | 1.28% |
22,202
+847
| +4% | +$149K |
|
27
Marriott International Class A Common Stock
MAR
$72.9B
| $3.78M | 1.23% |
30,185
-961
| -3% | -$120K |
|
|
28
Progressive
PGR
$146B
| $3.73M | 1.22% |
51,705
+20,890
| +68% | +$1.51M |
|
29
GSK
GSK
$79.7B
| $3.49M | 1.14% |
66,750
+4,154
| +7% | +$217K |
|
30
Texas Instruments
TXN
$170B
| $3.48M | 1.14% |
32,801
+426
| +1% | +$45.2K |
|
31
Marsh & McLennan
MMC
$101B
| $3.26M | 1.07% |
34,763
+585
| +2% | +$54.9K |
|
32
PepsiCo
PEP
$201B
| $3.22M | 1.05% |
26,263
+1,495
| +6% | +$183K |
|
33
Church & Dwight Co
CHD
$23B
| $3.17M | 1.04% |
44,466
-1,219
| -3% | -$86.8K |
|
34
Illinois Tool Works
ITW
$76.9B
| $3.02M | 0.99% |
21,034
+1,630
| +8% | +$234K |
|
35
AbbVie
ABBV
$376B
| $2.96M | 0.97% |
36,685
+3,930
| +12% | +$317K |
|
36
Abbott
ABT
$233B
| $2.92M | 0.96% |
36,555
+1,230
| +3% | +$98.3K |
|
37
EOG Resources
EOG
$66.3B
| $2.9M | 0.95% |
30,418
-1,319
| -4% | -$126K |
|
38
Baxter International
BAX
$12.1B
| $2.86M | 0.93% |
35,115
-220
| -0.6% | -$17.9K |
|
|
39
Linde
LIN
$221B
| $2.84M | 0.93% |
+16,135
| New | +$2.84M |
|
40
Novartis
NVS
$249B
| $2.82M | 0.92% |
32,769
-112
| -0.3% | -$9.65K |
|
41
Duke Energy
DUK
$93.9B
| $2.5M | 0.82% |
27,782
-88
| -0.3% | -$7.92K |
|
|
42
Citizens Financial Group
CFG
$22.4B
| $2.32M | 0.76% |
71,385
+71,085
| +23,695% | +$2.31M |
|
43
McDonald's
MCD
$228B
| $2.26M | 0.74% |
11,893
+70
| +0.6% | +$13.3K |
|
44
Emerson Electric
EMR
$74B
| $2.26M | 0.74% |
32,960
+1,850
| +6% | +$127K |
|
45
Thermo Fisher Scientific
TMO
$183B
| $2.12M | 0.69% |
7,738
+350
| +5% | +$95.8K |
|
46
IBM
IBM
$231B
| $2M | 0.65% |
14,850
+235
| +2% | +$31.7K |
|
47
Colgate-Palmolive
CL
$67.6B
| $1.98M | 0.65% |
28,874
+366
| +1% | +$25.1K |
|
48
AT&T
T
$211B
| $1.89M | 0.62% |
79,583
+1
| +0% | +$24 |
|
49
DuPont de Nemours
DD
$31.7B
| $1.88M | 0.61% |
17,444
| – | – |
|
50
Schlumberger
SLB
$53.2B
| $1.87M | 0.61% |
42,981
+1,420
| +3% | +$61.9K |
|